Safe IV logo

Pre-filled flush syringes with methylene blue indicator dye

We are looking for suitable partners to work with us to license this new patented* medical device

INTERESTED – CONTACT US TODAY

Reducing the risks to patients when intravenous (IV) drugs are retained in cannulae and extension lines

what people say

  • ‘There are pre-filled flush syringes available today to support efforts to reduce the risk of medication errors, but these only contain colourless heparinised saline or sodium chloride, these are identical in appearance to the harmful drugs making it impossible to check whether cannulae or extension lines have been flushed for further use.’

  • ‘There are no records as to the level of incidence and we suspect the level is under reported. The National Reporting and Learning System (NRLS) does have some records of incidents being reported involving either anaesthetic or sedative drugs in adults or children.’

  • ‘Despite the issuing of multiple safety alerts and hospital checklists, residual drugs in cannulae and extension line events continue to happen with risks of hypoxic brain injury or even death.’

  • ‘Some drugs, such as those used in anaesthesia and pain management, can cause patients to go into cardiac or respiratory arrest. After administration, these drugs should be flushed through cannulae and extension lines to make sure no residual quantities of the drugs are left.’

Kathryn shares her personal story 

In this video Kathryn shares her personal story of the harm she experienced when her cannula wasn’t flushed following surgery

The solution to reduce the
risks to patients by Dr Steven Gill,
Consultant Anaesthetist

‘My aim as a Consultant in Anaesthesia at Leeds Teaching Hospital, is to make the flushing of retained intravenous (IV) drugs in cannulae and extension lines a never event.’

‘The answer, I believe, is to produce a pre-filled flush syringe containing a dilute solution of methylene blue, rather than the current colourless saline solution. This will give a positive visual indication, by the bedside, that the cannula or extension has been adequately flushed and contains no harmful residual drugs.’

Intravenous (IV) drugs being retained in cannulae and extension lines is a very serious, completely preventable occurrence that the current system of paperwork checks and checklists have failed to prevent.

‘We are therefore looking for suitable partners to work with us to license this new patented* medical device.’

INTERESTED – CONTACT US TODAY
* This new medical device has been granted US and European patents, ask for details
Steven Gill